BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ogawa K, Nakamura K, Hatano K, Uno T, Fuwa N, Itami J, Kojya S, Nakashima T, Shinhama A, Nakagawa T, Toita T, Sakai M, Kodaira T, Suzuki M, Ito H, Murayama S. Treatment and Prognosis of Squamous Cell Carcinoma of the External Auditory Canal and Middle Ear: A Multi-Institutional Retrospective Review of 87 Patients. International Journal of Radiation Oncology*Biology*Physics 2007;68:1326-34. [DOI: 10.1016/j.ijrobp.2007.01.052] [Cited by in Crossref: 73] [Cited by in F6Publishing: 52] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Lionello M, Stritoni P, Facciolo M, Staffieri A, Martini A, Mazzoni A, Zanoletti E, Marioni G. Temporal bone carcinoma. Current diagnostic, therapeutic, and prognostic concepts: Temporal Bone Carcinoma. J Surg Oncol 2014;110:383-92. [DOI: 10.1002/jso.23660] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
2 Choi J, Kim SH, Koh YW, Choi EC, Lee CG, Keum KC. Tumor Stage-Related Role of Radiotherapy in Patients with an External Auditory Canal and Middle Ear Carcinoma. Cancer Res Treat 2017;49:178-84. [PMID: 27384159 DOI: 10.4143/crt.2016.165] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
3 Basura GJ, Smith JD, Ellsperman S, Bhangale A, Brenner JC. Targeted molecular characterization of external auditory canal squamous cell carcinomas. Laryngoscope Investig Otolaryngol 2021;6:1151-7. [PMID: 34667860 DOI: 10.1002/lio2.654] [Reference Citation Analysis]
4 Iwami K, Fujii M, Nishio N, Maruo T, Yoshida T, Mukoyama N, Osuka K, Takanari K, Murotani K, Kamei Y, Sone M, Fujimoto Y, Saito K. Surgical Classification of Radical Temporal Bone Resection and Transcranial Tympanotomy: A Retrospective Study from the Neurosurgical Perspective. World Neurosurg 2021;151:e192-207. [PMID: 33862297 DOI: 10.1016/j.wneu.2021.04.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Oya R, Takenaka Y, Takemura K, Ashida N, Shimizu K, Kitamura T, Yamamoto Y, Uno A. Surgery With or Without Postoperative Radiation Therapy for Early-stage External Auditory Canal Squamous Cell Carcinoma: A Meta-analysis. Otology & Neurotology 2017;38:1333-8. [DOI: 10.1097/mao.0000000000001533] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
6 Takenaka Y, Cho H, Nakahara S, Yamamoto Y, Yasui T, Inohara H. Chemoradiation therapy for squamous cell carcinoma of the external auditory canal: A meta-analysis. Head Neck 2015;37:1073-80. [PMID: 24692266 DOI: 10.1002/hed.23698] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
7 Ito M, Hatano M, Yoshizaki T. Prognostic factors for squamous cell carcinoma of the temporal bone: extensive bone involvement or extensive soft tissue involvement? Acta Oto-Laryngologica 2009;129:1313-9. [DOI: 10.3109/00016480802642096] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
8 Shiga K, Nibu KI, Fujimoto Y, Asakage T, Homma A, Mitani H, Ogawa T, Okami K, Murono S, Hirano S, Ueda T, Hanai N, Tsukahara K, Ota I, Yoshimoto S, Shinozaki T, Iwae S, Katagiri K, Saito D, Kiyota N, Tahara M, Takahashi F, Hayashi R. Sites of invasion of cancer of the external auditory canal predicting oncologic outcomes. Head Neck 2021;43:3097-105. [PMID: 34240528 DOI: 10.1002/hed.26800] [Reference Citation Analysis]
9 Gidley PW, Demonte F. Temporal Bone Malignancies. Neurosurgery Clinics of North America 2013;24:97-110. [DOI: 10.1016/j.nec.2012.08.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
10 Marioni G, Zanoletti E, Giacomelli L, Braggio L, Martini A, Mazzoni A. Clinical and pathological parameters prognostic for increased risk of recurrence after postoperative radiotherapy for temporal bone carcinoma: Temporal bone SCC prognosis after postoperative RT. Head Neck 2016;38:894-8. [DOI: 10.1002/hed.24221] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
11 Zanoletti E, Lovato A, Stritoni P, Martini A, Mazzoni A, Marioni G. A critical look at persistent problems in the diagnosis, staging and treatment of temporal bone carcinoma. Cancer Treatment Reviews 2015;41:821-6. [DOI: 10.1016/j.ctrv.2015.10.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
12 Ebisumoto K, Okami K, Hamada M, Maki D, Sakai A, Saito K, Shimizu F, Kaneda S, Iida M. Cetuximab with radiotherapy as an alternative treatment for advanced squamous cell carcinoma of the temporal bone. Auris Nasus Larynx. 2018;45:637-639. [PMID: 28867454 DOI: 10.1016/j.anl.2017.08.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ahmed MK, Ishino T, Hirakawa K, Arihiro K. Syringoid eccrine carcinoma of external auditory canal. A case report. Auris Nasus Larynx 2010;37:519-21. [PMID: 20172670 DOI: 10.1016/j.anl.2009.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
14 Kang H, Wu H, Lee JH, Park CI, Kim C, Oh SH, Heo D, Kim D, Lee S. Role of Radiotherapy for Squamous Cell Carcinoma of the External Auditory Canal and Middle Ear. J Korean Soc Ther Radiol Oncol 2009;27:173. [DOI: 10.3857/jkstro.2009.27.4.173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Morris LG, Mehra S, Shah JP, Bilsky MH, Selesnick SH, Kraus DH. Predictors of survival and recurrence after temporal bone resection for cancer. Head Neck 2012;34:1231-9. [PMID: 21953902 DOI: 10.1002/hed.21883] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 5.5] [Reference Citation Analysis]
16 Ihler F, Koopmann M, Weiss BG, Dröge LH, Durisin M, Christiansen H, Weiß D, Canis M, Wolff HA. Surgical margins and oncologic results after carcinoma of the external auditory canal: Outcome of Auditory Canal Carcinoma. The Laryngoscope 2015;125:2107-12. [DOI: 10.1002/lary.25381] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
17 Lovin BD, Gidley PW. Squamous cell carcinoma of the temporal bone: A current review. Laryngoscope Investig Otolaryngol. 2019;4:684-692. [PMID: 31890889 DOI: 10.1002/lio2.330] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
18 Nagano T, Yoshimura RI, Kojima M, Nakagawa K, Toda K. Outcomes of radiotherapy in advanced external auditory canal cancer. J Radiat Res 2019;60:380-6. [PMID: 31116854 DOI: 10.1093/jrr/rrz010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Park JM, Kong JS, Chang KH, Jun BC, Jeon EJ, Park SY, Park SN, Park KH. The Clinical Characteristics and Surgical Outcomes of Carcinoma of the External Auditory Canal: A Multicenter Study. J Int Adv Otol 2018;14:278-84. [PMID: 30256202 DOI: 10.5152/iao.2018.4952] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
20 Bacciu A, Clemente IA, Piccirillo E, Ferrari S, Sanna M. Guidelines for Treating Temporal Bone Carcinoma Based on Long-Term Outcomes. Otology & Neurotology 2013;34:898-907. [DOI: 10.1097/mao.0b013e318281e0a9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
21 Chi FL, Gu FM, Dai CF, Chen B, Li HW. Survival outcomes in surgical treatment of 72 cases of squamous cell carcinoma of the temporal bone. Otol Neurotol 2011;32:665-9. [PMID: 21436754 DOI: 10.1097/MAO.0b013e318210b90f] [Cited by in Crossref: 45] [Cited by in F6Publishing: 15] [Article Influence: 4.1] [Reference Citation Analysis]
22 Shiga K, Nibu KI, Fujimoto Y, Asakage T, Homma A, Mitani H, Ogawa T, Okami K, Murono S, Hirano S, Ueda T, Hanai N, Tsukahara K, Ota I, Yoshimoto S, Shinozaki T, Iwae S, Katagiri K, Saito D, Kiyota N, Tahara M, Takahashi F, Hayashi R. Multi-institutional Survey of Squamous Cell Carcinoma of the External Auditory Canal in Japan. Laryngoscope 2021;131:E870-4. [PMID: 33216374 DOI: 10.1002/lary.28936] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Kline NL, Bhatnagar K, Eisenman DJ, Taylor RJ. Survival outcomes of lateral skull base tumors following temporal bone resection. Head Neck 2021;43:2414-22. [PMID: 33851465 DOI: 10.1002/hed.26707] [Reference Citation Analysis]
24 Prabhu R, Hinerman RW, Indelicato DJ, Morris CG, Werning JW, Vaysberg M, Amdur RJ, Kirwan J, Mendenhall WM. Squamous Cell Carcinoma of the External Auditory Canal: Long-Term Clinical Outcomes Using Surgery and External-Beam Radiotherapy. American Journal of Clinical Oncology 2009;32:401-4. [DOI: 10.1097/coc.0b013e31818f2d48] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
25 Katano A, Takenaka R, Yamashita H, Ando M, Yoshida M, Saito Y, Asakage T, Abe O, Nakagawa K. A retrospective analysis of radiotherapy in the treatment of external auditory canal carcinoma. Mol Clin Oncol 2021;14:45. [PMID: 33575029 DOI: 10.3892/mco.2021.2207] [Reference Citation Analysis]
26 García-Marín R, Cabal VN, Fernández-Cedrón Bermejo C, Riobello C, Suárez-Fernández L, Codina-Martínez H, Navarro-García A, Lorenzo-Guerra SL, García-Martínez J, Vivanco B, López F, Llorente JL, Hermsen MA. A Novel External Auditory Canal Squamous Cell Carcinoma Cell Line Sensitive to CDK4/6 Inhibition. Otolaryngol Head Neck Surg 2022;:1945998221089186. [PMID: 35349366 DOI: 10.1177/01945998221089186] [Reference Citation Analysis]
27 Hayashi K, Koto M, Demizu Y, Saitoh JI, Suefuji H, Okimoto T, Ohno T, Shioyama Y, Takagi R, Ikawa H, Nemoto K, Nakano T, Kamada T. A retrospective multicenter study of carbon-ion radiotherapy for external auditory canal and middle ear carcinomas. Cancer Med 2019;8:51-7. [PMID: 30548207 DOI: 10.1002/cam4.1830] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
28 McCracken M, Pai K, Cabrera CI, Johnson BR, Tamaki A, Gidley PW, Manzoor NF. Temporal Bone Resection for Squamous Cell Carcinoma of the Lateral Skull Base: Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg 2022;:1945998221084912. [PMID: 35290141 DOI: 10.1177/01945998221084912] [Reference Citation Analysis]
29 Chen W, Kuo S, Chen Y, Lu S, Tsai C, Chia-hsien Cheng J, Hong R, Chen Y, Hsu C, Lin K, Ko J, Lou P, Wang C, Chong F, Wang C. Postoperative Intensity-Modulated Radiotherapy for Squamous Cell Carcinoma of the External Auditory Canal and Middle Ear: Treatment Outcomes, Marginal Misses, and Perspective on Target Delineation. International Journal of Radiation Oncology*Biology*Physics 2012;82:1485-93. [DOI: 10.1016/j.ijrobp.2011.05.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
30 Iwami K, Fujii M, Nishio N, Maruo T, Fujimoto Y, Takanari K, Kamei Y, Yamada M, Ogawa T, Osuka K, Saito K. Skull Base Invasion Patterns of Malignant Head and Neck Tumors: A Neurosurgical Perspective. J Neurol Surg B Skull Base 2021;82:e120-30. [PMID: 34306927 DOI: 10.1055/s-0039-3402034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Ouaz K, Robier A, Lescanne E, Bobillier C, Morinière S, Bakhos D. Cancer of the external auditory canal. Eur Ann Otorhinolaryngol Head Neck Dis 2013;130:175-82. [PMID: 23845289 DOI: 10.1016/j.anorl.2012.08.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
32 Ueda Y, Kurita T, Matsuda Y, Ito S, Nakashima T. Superselective, intra-arterial, rapid infusion chemotherapy for external auditory canal carcinoma. J Laryngol Otol 2009;123:75-80. [DOI: 10.1017/s0022215109005143] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
33 Homma A, Onimaru R, Matsuura K, Robbins KT, Fujii M. Intra-arterial chemoradiotherapy for head and neck cancer. Jpn J Clin Oncol 2016;46:4-12. [PMID: 26486825 DOI: 10.1093/jjco/hyv151] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
34 Kloss B, Lapoint J, Dougher K. Auricular squamous cell carcinoma. Int J Emerg Med 2011;4:50. [PMID: 21824416 DOI: 10.1186/1865-1380-4-50] [Reference Citation Analysis]
35 Qiu K, Pang W, Qiu J, Li J, Cheng D, Rao Y, Dong Y, Mao M, Liu Q, Mu X, Zhang W, Xu W, Ren J, Zhao Y. Evaluating the prognostic contributions of TNM classifications and building novel staging schemes for middle ear squamous cell carcinoma. Cancer Med 2021;10:7958-67. [PMID: 34559476 DOI: 10.1002/cam4.4306] [Reference Citation Analysis]
36 Visnyei K, Gill R, Azizi E, Culliney B. Squamous cell carcinoma of the external auditory canal: A case report and review of the literature. Oncol Lett 2013;5:1587-90. [PMID: 23761823 DOI: 10.3892/ol.2013.1241] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
37 Gandhi AK, Roy S, Biswas A, Raza MW, Saxena T, Bhasker S, Sharma A, Thakar A, Mohanti BK. Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience. Auris Nasus Larynx 2016;43:45-9. [DOI: 10.1016/j.anl.2015.06.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
38 George M, Borsotti F, Gereige R, Kolethekkat AA, Das A, Messerer M, Mahasampath G, Simon C. A systematic review of the primary squamous cell carcinoma of the external auditory canal: survival outcome based on T-staging and proposal of a new classification. J Laryngol Otol 2021;135:96-103. [PMID: 33568243 DOI: 10.1017/S0022215121000323] [Reference Citation Analysis]
39 Matoba T, Hanai N, Suzuki H, Nishikawa D, Tachibana E, Okada T, Murakami S, Hasegawa Y. Treatment and Outcomes of Carcinoma of the External and Middle Ear: The Validity of En Bloc Resection for Advanced Tumor. Neurol Med Chir (Tokyo) 2018;58:32-8. [PMID: 29142161 DOI: 10.2176/nmc.oa.2017-0133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
40 Alam U, Shafqat I, Ahsan S, Alonso J, Han AY, Mukdad L, Wang M, Ahsan SF. Survival in Middle Ear Malignancy: A Population-Based Analysis Based on the SEER Database. Otolaryngol Head Neck Surg 2021;165:122-8. [PMID: 33400624 DOI: 10.1177/0194599820980708] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Wang Z, Zheng M, Xia S. The contribution of CT and MRI in staging, treatment planning and prognosis prediction of malignant tumors of external auditory canal. Clin Imaging 2016;40:1262-8. [PMID: 27639864 DOI: 10.1016/j.clinimag.2016.08.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
42 Zanoletti E, Marioni G, Stritoni P, Lionello M, Giacomelli L, Martini A, Mazzoni A. Temporal bone squamous cell carcinoma: Analyzing prognosis with univariate and multivariate models: Temporal Bone SCC Prognosis. The Laryngoscope 2014;124:1192-8. [DOI: 10.1002/lary.24400] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
43 Brant JA, Eliades SJ, Chen J, Newman JG, Ruckenstein MJ. Carcinoma of the Middle Ear: A Review of the National Cancer Database. Otol Neurotol 2017;38:1153-7. [PMID: 28692593 DOI: 10.1097/MAO.0000000000001491] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
44 Kitani Y, Kubota A, Furukawa M, Sato K, Nakayama Y, Nonaka T, Mizoguchi N. Primary definitive radiotherapy with or without chemotherapy for squamous cell carcinoma of the temporal bone. Eur Arch Otorhinolaryngol 2016;273:1293-8. [PMID: 25822291 DOI: 10.1007/s00405-015-3616-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
45 Budrukkar A, Bahl G, Bhalavat R, Laskar SG, Agarwal JP, Jamema SV, Patil K. High-dose-rate brachytherapy boost for carcinoma of external auditory canal. Brachytherapy 2009;8:392-5. [PMID: 19734107 DOI: 10.1016/j.brachy.2009.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
46 Gallegos-Hernández JF, Martínez-Méndez MÁ, Ábrego-Vázquez JA, Hernández-Sanjuan M, Minauro-Muñoz GG, Ortiz-Maldonado AL. [Clinical characteristics of malignant tumours originating in the external ear]. Cir Cir 2015;83:473-7. [PMID: 26183026 DOI: 10.1016/j.circir.2015.06.002] [Reference Citation Analysis]
47 Makita K, Hamamoto Y, Takata N, Ishikawa H, Tsuruoka S, Uwatsu K, Hato N, Kido T. Prognostic significance of inflammatory response markers for locally advanced squamous cell carcinoma of the external auditory canal and middle ear. J Radiat Res 2021;62:662-8. [PMID: 34115873 DOI: 10.1093/jrr/rrab048] [Reference Citation Analysis]
48 Jia X, Liang Q, Chi F. Treatment and outcome of middle ear cancer. Eur Arch Otorhinolaryngol 2014;271:2675-80. [DOI: 10.1007/s00405-013-2728-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
49 Lo WC, Ting LL, Ko JY, Lou PJ, Yang TL, Chang YL, Wang CP. Malignancies of the ear in irradiated patients of nasopharyngeal carcinoma. Laryngoscope 2008;118:2151-5. [PMID: 18948828 DOI: 10.1097/MLG.0b013e3181839b8c] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
50 Wei L, Wang L, Liu Z, Wang M, Lu W, Zhao D, Yang B, Kong X, Ding Y, Wang Z. Dramatic response of CTNNB1 and VEGFR-2 mutant temporal bone squamous cell carcinoma to bevacizumab in combination with pemetrexed. Oncotarget 2017;8:57898-904. [PMID: 28915721 DOI: 10.18632/oncotarget.19649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
51 Feng L, Jin A, Dai B, Li Y, Guo Y, Wang D, Xu P. Outcomes of 18 cases with squamous cell carcinoma of middle ear who underwent both surgery and post-operative radiotherapy. Acta Otolaryngol 2016;136:141-3. [PMID: 26472473 DOI: 10.3109/00016489.2015.1094825] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
52 Fujiwara M, Yamamoto S, Doi H, Takada Y, Odawara S, Niwa Y, Ishikura R, Kamikonya N, Terada T, Uwa N, Sagawa K, Hirota S. Arterial chemoradiotherapy for carcinomas of the external auditory canal and middle ear: Carcinomas of the Lateral Skull Base. The Laryngoscope 2015;125:685-9. [DOI: 10.1002/lary.24908] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
53 Koto M, Hasegawa A, Takagi R, Sasahara G, Ikawa H, Mizoe J, Jingu K, Tsujii H, Kamada T, Okamoto Y; Organizing Committee for the Working Group for Head and Neck Cancer. Carbon ion radiotherapy for locally advanced squamous cell carcinoma of the external auditory canal and middle ear: Carbon ion radiotherapy for SCC of the ear. Head Neck 2016;38:512-6. [DOI: 10.1002/hed.23905] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
54 Gurgel RK, Karnell LH, Hansen MR. Middle ear cancer: A population-based study: Middle Ear Cancer. The Laryngoscope 2009;119:1913-7. [DOI: 10.1002/lary.20202] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
55 Shinomiya H, Uehara N, Fujita T, Yoshida K, Imamura Y, Teshima M, Kimura H, Miyawaki D, Kakigi A, Kiyota N, Otsuki N, Sasaki R, Kohmura E, Nibu K. New proposal to revise the classification for squamous cell carcinoma of the external auditory canal and middle ear. J Laryngol Otol 2021;135:297-303. [PMID: 33785085 DOI: 10.1017/S002221512100089X] [Reference Citation Analysis]
56 Murai T, Kamata SE, Sato K, Miura K, Inoue M, Yokota N, Ohta S, Iwabuchi M, Iwata H, Shibamoto Y. Hypofractionated Stereotactic Radiotherapy for Auditory Canal or Middle Ear Cancer. Cancer Control 2016;23:311-6. [PMID: 27556672 DOI: 10.1177/107327481602300315] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]